Skip to main content

Distinguished Speaker Series | Konstantin Petrukhin, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Brunson Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

May 15, 2026 | Konstantin Petrukhin, PhD

Expanding Beyond the Visual Cycle: Convergent Pharmacology of Retinal Clearance in Macular Degeneration

 

Learn More About the Distinguished Speaker Series

Featured


Konstantin Petrukhin, PhD
Konstantin Petrukhin, PhD
  • Konstantin Petrukhin, PhD, Professor of Ophthalmic Science, Department of Ophthalmology, Columbia University Irving Medical Center

Konstantin Petrukhin, PhD, is a Professor of Ophthalmic Science in the Department of Ophthalmology at Columbia University Vagelos College of Physicians and Surgeons. His research focuses on retinal degenerative diseases, with particular emphasis on age-related macular degeneration (AMD) and Stargardt disease. Dr. Petrukhin’s work explores the molecular mechanisms underlying retinal damage, including the accumulation of toxic lipofuscin byproducts and the degeneration of retinal pigment epithelium and photoreceptors. His laboratory investigates therapeutic strategies aimed at preserving retinal structure and function, including the development of small-molecule inhibitors to reduce toxic bisretinoid formation, modulation of nuclear receptor pathways to promote photoreceptor survival, and targeting gliotic responses in retinal cells. By integrating molecular biology, pharmacology, and translational research approaches, his work seeks to advance innovative treatments that slow disease progression and improve visual outcomes in patients with retinal disorders